Weekly Legislative Update 6/10/17

revolutionbumperWelcome to this week’s edition of the NORML legislative roundup!

First off, apologies to weekly readers for skipping last week’s update. We held a NORML Legal Committee seminar in Colorado about tactics to continue the fight against prohibition and protect those facing jail and other adverse ramifications of prohibition. You can watch NORML’s Executive Director give the opening welcome HERE and click here to read a write up on it in The Denver Post’s Cannabist HERE.

In the last two weeks, four pieces of legislation that we are supportive of went into law:

Colorado
Senate Bill 17 adds “stress disorders” (PTSD) to the list of debilitating conditions for which a physician may recommend cannabis.

Maryland
House Bill 379 / Senate Bill 949 went into effect May 27 to permit those who received a criminal marijuana possession conviction prior to October 1, 2014, to seek expungement of their records.

Often minor marijuana possession offenders, many of them young people, face the lifelong penalties and stigma associated with having a record, even when the state no longer considers simple possession to be a crime.

Nevada
Assembly Bill 135 eliminates statutes criminalizing the operation of a motor vehicle if a driver has detectable levels of carboxy THC in his/her urine. Carboxy-THC is an non-psychoactive waste product of THC that may be present for days or even weeks post-abstinence. It’s presence in urine is not correlated with psychomotor impairment.

While passage of AB 135 is a step in the right direction, further legislation will continue to be necessary in order to amend Nevada’s traffic safety laws in a manner that no longer inadvertently criminalize responsible adult marijuana consumers in regards to blood testing.

Vermont
SB 16 permits physicians for the first time to recommend medical marijuana to patients with post-traumatic stress, Crohn’s disease, or Parkinson’s disease. The measure also allows physicians to immediately issue medical cannabis recommendations for patients suffering from cancer, a terminal illness, or under hospice care supervision.

Unfortunately, in Montana, SB 333, was signed into law to amend the state’s medical cannabis program, I-182, which voters passed in November.

The measure establishes various rules and regulations regarding the operation of cannabis dispensaries, production facilities, and testing labs. It does not amend the expanded list of qualifying conditions enacted by I-182. However, SB 333 does impose new taxes on medical marijuana gross sales. NORML opposes taxes of medical cannabis. It also reduces the number of seedlings qualified patients are permitted to possess at home from 12 to no more than four. It also imposes limits regarding the total harvest of cannabis permitted per patient.

Following are the bills from around the country that we’ve tracked this week and as always, check http://norml.org/act for legislation pending in your state.

Don’t forget to sign up for our email list and we will keep you posted as these bills and more move through your home state legislature and at the federal level.

Thanks for all you do and keep fighting,
Justin

Priority Alerts
Federal
Join The Caucus: With public support for reforming marijuana laws at an all time high, Reps. Earl Blumenauer (D-OR), Dana Rohrabacher (R-CA), Jared Polis (D-CO), and Don Young (R-AK) earlier this year formed the Congressional Cannabis Caucus to develop and promote sensible cannabis policy reform and work to ease the tension between federal and state cannabis laws.

Click here to email your Member of Congress to urge them to join the Congressional Cannabis Caucus

California
Legislation is pending, Assembly Bill 1578, to try and limit potential federal interference in the state’s marijuana regulatory laws.

The bill states, “This bill would prohibit a state or local agency, as defined, from taking certain actions without a court order signed by a judge, including using agency money, facilities, property, equipment, or personnel to assist a federal agency to investigate, detain, detect, report, or arrest a person for commercial or noncommercial marijuana or medical cannabis activity that is authorized by law in the State of California and transferring an individual to federal law enforcement authorities for purposes of marijuana enforcement.”

The majority of Californians desire a legally regulated marijuana market. Passage of this act will limit state or local agencies from working with the federal government to undermine these regulations.

Update: AB 1578 passed the Assembly on June 1 and now moves to the Senate for consideration.

CA resident? Click here to send a message to your state Senator in support of this effort. 

Louisiana
SB 35 provides explicit exemptions from arrest and prosecution for persons lawfully in possession of medical marijuana.

Presently, state regulators are finalizing rules and regulations governing its nascent medical cannabis program, which seeks to permit the production, dispensing, and use of non-herbal preparations of cannabis for qualified patients. Passage of SB 36 amends various criminal statutes to assure that those involved in the program are not inadvertently subject to criminal liability.

Specifically, it provides immunity from arrest for those enrolled in the program who engage in activities related to the purchase or transportation of medical marijuana related products or paraphernalia. It provides further legal protections for pharmacies, producers, and testing laboratories engaged in medical cannabis related activities.

Update: House members amended and passed SB 35 by a vote of 74 to 21 on June 5. Senate members approved the House changes on June 6. The reconciled bill was transmitted to the Governor.

LA resident? Click here to send a message to the Governor in support of SB 35. 

New Hampshire
After nearly a decade of frustration, 2017 is finally the year that New Hampshire voters successfully see marijuana possession decriminalized.

HB 640, will amend criminal penalties for marijuana possession is pending in the House, where lawmakers have overwhelmingly supported such efforts for eight years in a row. However, legislators this year are hopeful that, for the first time, they also have sufficient votes to also clear the Senate.

Update: The House concurred with the amended Senate bill on June 1 and the bill will soon be transmitted to the Governor.

NH resident? Click here to send a message to the Governor thanking him for his support of decriminalization. 

Rhode Island
Sponsors have announced plans to amend their legislation in a manner that would legalize the possession of up to one ounce of cannabis, effective July 1, 2018. The amended legislation would also establish an advisory committee to issue a report to the General Assembly by January 1, 2018 with recommendations regarding how best to establish a system for taxing and regulating marijuana in Rhode Island. Sen. Miller said, “We are prepared to compromise in a significant way, but there must be progress on the issue this year. Our proposal balances the will of the majority of voters who want marijuana to be legal for adults while respecting colleagues who want to slow things down and get the regulations right.”

RI resident? Click here to send a message to your elected officials in support of this effort. 

Other Actions to Take

Massachusetts
Legislation is pending before the House, H 113, to prohibit employers from discriminating against patients who legally consume marijuana during non-work hours. Additional legislation, H 2385, would expand protections for medical marijuana patients so that they may not be discriminated against with regard to housing, higher education, and child custody issues.

Changes in the legal status of marijuana has not been associated with any adverse changes in workplace safety. In fact, a pair of studies from 2016 find that legalization is associated with greater workforce participation and with fewer workplace absences. Most recently, the National Academies of Sciences just-released marijuana and health report found “insufficient evidence” to support an association between cannabis use and occupational accidents or injuries.

MA resident? Click here to send a message to your elected officials in support of this effort. 

New Hampshire
Legislation is pending in the New Hampshire House, HB 215, to establish a commission to study the legalization, regulation, and taxation of marijuana.

Police in New Hampshire arrest some 2,900 individuals annually for simple marijuana possession offenses. The continued criminalization of adult marijuana use is out-of-step with the views of New Hampshire adults, 62 percent of whom now endorse legalizing and regulating cannabis, according to a 2016 WMUR Granite State Poll.

Update: The House has adopted the Senate changes. The bill is expected to be transmitted to the Governor imminently.

NH resident? Click here to send a message to the Governor urging him to sign HB 215

Additionally, multiple bills are pending to expand the pool of patients eligible to qualify for medical marijuana therapy.

In particular, these measures would permit patients with conditions like chronic pain and post-traumatic stress to obtain legal access to marijuana.

NH resident? Click here to contact your elected officials to support patients. 

New York
A pair of bills are pending in the Senate to expand patients’ access to medical cannabis.

Senate Bill 6092 expands the pool of patients eligible for medical cannabis access to include those with Alzheimer’s disease, lupus, rheumatoid arthritis and a number of other debilitating diseases. It also removes arbitrary caps imposed on the amount of THC permitted in oral products.

Senate Bill 6308 allows for additional cannabis providers to operate in the state in order to improve patients’ access.

NY resident? Click here to send a message to your lawmakers in support of these bills. 

Rhode Island
SB 176 is currently pending in the Rhode Island Senate. It amends the state’s Medical Marijuana Act, which currently only permits three medical marijuana dispensaries to operate in the entire state, to permit regulators to license up to six total dispensaries.

In recent years, the total number of registered medical cannabis patients in Rhode Island has nearly doubled to more than 17,000 people. It is necessary for regulators to license additional dispensaries in order to keep up with this increased demand.

RI resident? Click here to send a message to your lawmakers in support of this effort. 

NORML Blog, Marijuana Law Reform

Categories: Hemp History | Tags: , , , | Leave a comment

Safe Streets Alliance et al. v. John Hickenlooper, et al. – Good News, Bad News

C1_8734_r_xA ruling issued on June 7th by the US Court of Appeals for the Tenth Circuit, in response to a series of legal challenges to Colorado’s adult cannabis use regulations, includes both good news and bad news.

The Good News

Most importantly for the legalization movement nationwide, the appeals court rejected the argument raised by the states of Nebraska and Oklahoma that Amendment 64 in Colorado, the voter initiative that legalized and regulated the adult use of marijuana, was preempted by the federal Controlled Substances Act. That argument, made by these neighboring states, if accepted by the court, would have voided Amendment 64.

It should be noted that this was not a definitive ruling on the federal preemption argument. Rather, it was a procedural ruling, finding that only the US Supreme Court has jurisdiction to hear disputes between the states. (The Supreme Court declined to consider a similar challenge in 2016.)

In fact, it was only after the Supreme Court had rejected their motion that the two states elected to raise these same issues with the 10th Circuit, by filing a motion to intervene in the Safe Streets case.

Also a big win, the Circuit Court rejected a similar attempt by a group of sheriffs and prosecutors from Colorado, Kansas, and Nebraska to use the US Controlled Substances Act and the Supremacy Clause of the US Constitution to enjoin the enforcement of Amendment 64. The court found that the Supremacy Clause “does not give rise to a private right of action.”

Hopefully this will give pause to other anti-marijuana zealots out there who might wish to use the federal preemption argument to undermine the various state legalization laws.

The Bad News

The bad news is that the 10th Circuit did reinstate a civil RICO complaint filed by private landowners in Colorado against a state-licensed indoor cultivation center, alleging it had caused a noxious odor that damaged their property value. The appellate court remanded the case back to the US District Court for further proceedings to allow the plaintiffs to attempt to prove their RICO claims.

While this is necessarily concerning to those in the state-legal cultivation industry, since the problems presented by the odors emanating from large grow operations is a theme which has been raised in several Colorado communities, it likely does not open the floodgates for every neighbor to bring a RICO suit against any cultivation center. Rather it likely will accelerate the adoption of the most effective technology by cultivation centers to minimize the odor of marijuana.

In the court’s own words, “We are not suggesting that every private citizen purportedly aggrieved by another person, a group, or an enterprise that is manufacturing, distributing, selling, or using marijuana may pursue a claim under RICO. Nor are we implying that every person tangentially injured in his business or property by such activities has a viable RICO claim. Rather, we hold only that the Reillys alleged sufficient facts to plausibly establish the requisite elements of their claims against the Marijuana Growers here.”

NORML Blog, Marijuana Law Reform

Categories: Hemp History | Tags: , , , , , , | Leave a comment

This Pharmaceutical Company Wants To Prove Cannabis Destroys Cancer

TREE

Submitted by Marijuana News on Wed, 06/07/2017 – 08:25

CURE Pharmaceutical, a technologically-based drug delivery platform and its partner, Technion-Israel Institute of Technology will be conducting a clinical study to test whether cannabinoid compounds will reduce or eliminate cancerous cells.

Can cannabis really make cancer disappear?

Cannabis as a cancer treatment not only for it symptoms but as a possible cure has been hotly debated and researched for some time.

Federally, the government does accept that cancer-related side effects such as decreased appetite, nausea and pain relief can be treated with cannabis, but as for cancer itself, patients and those in the medical field have only been able to anecdotally link cannabis to the destruction of cancerous cells and tumors.

CURE Pharmaceutical is researching this link head on, in its first ever clinical study of this nature. Brian Higuera, the father of a 4-year-old liver cancer patient says there’s a strong possibility after he witnessed the shrinking of his daughter’s liver tumors, along with one that fully disappeared; all after being administered CBD oil.

The tumors are believed to have been removed due to her cannabis use in which [a brand of] CBD (called Real Scientific Hemp Oil) was a major portion of the cannabinoids in her oil along with THC and CBN.

[But] without a study to prove the cannabis oil is what cause the tumors to disappear, many say she is an anecdotal testimony.

CURE’s CEO, Rob Davidson looks to move beyond the anecdotal stage and provide solid proof to back up cases like Sadie’s. His goal is to prove the efficacy of cannabis with hard science behind it.

There is strong anecdotal evidence, but we want to put some science into it. First, we’ll do an in vitro study and see the effects on cancer cells. We can get into human trials pretty quickly in Israel.

Getting doctors onboard

Much of the reason that cannabis is kept from many patients is due to its federally illegal status. For this reason, not only is cannabis testing for cancer treatment sparsely conducted, but many physicians are left unable to prescribe cannabis legally.

Former Chief Resident at Los Angeles Children’s Hospital, Bonnie Goldstein says that studies like the one conducted by CURE can be highly beneficial in helping doctors prescribe cannabis to patients.

I currently take care of many patients, both adults and children, that have life-threatening advanced cancers and so far, I have been unable to match cannabis treatment to the patient’s specific cancer sub-type.

Initial studies show that different cancers respond to the anti-neoplastic effects of different cannabinoids. This research will answer this question and will allow physicians like myself to tailor treatment for cancer patients.

The study comes on the heels of CUREs announcement that the company will be entering the pharmaceutical cannabis sector. If so, many more studies that prove cannabis’ effects as a cure could be on the horizon and can appeal to many more in the medical profession who wish for more options to successfully treat patients.

CONTINUE READING…

Categories: US Hemp Co Museum | Leave a comment

Florida: Governor Vetoes Funding Effort For Medical Cannabis Research

Governor Rick Scott vetoed legislation that sought to provide some $ 3 million in medical cannabis research. The monies were earmarked for the Moffitt Cancer Center and the University of Florida. The Governor said that he believed that no additional taxpayer funds were necessary to fund state-sponsored cannabis research. 

National Organization for the Reform of Marijuana Laws – Advocacy Campaigns

Categories: Industrial Hemp Legislation | Tags: , , , , , , , | Leave a comment

Nevada: Governor Signs Hemp Expansion Law

Governor Brian Sandoval has signed legislation, Senate Bill 396, expanding the state’s hemp law to permit broader commercial cultivation of the crop.

The new law permits regulators to license growers to engage in hemp cultivation and to produce edible products derived from hemp.

Under a 2015 law, hemp could only be produced as part of a university-sponsored pilot program.

National Organization for the Reform of Marijuana Laws – Advocacy Campaigns

Categories: Industrial Hemp Legislation | Tags: , , , , | Leave a comment

Untitled

National Organization for the Reform of Marijuana Laws – Advocacy Campaigns

Categories: Industrial Hemp Legislation | Tags: | Leave a comment

Review Identifies 140 Controlled Clinical Trials Related to Cannabis

Marijuana researchScientists have conducted over 140 controlled clinical trials since 1975 assessing the safety and efficacy of whole-plant cannabis or specific cannabinoids, according to a new literature review published in the journal Critical Reviews in Plant Sciences.

A team of German researchers identified 140 clinical trials involving an estimated 8,000 participants. Of these, the largest body of literature focused on the use of cannabis or cannabinoids in the treatment of chronic or neuropathic pain. Authors identified 35 controlled studies, involving 2,046 subjects, assessing the use of marijuana in pain treatment. In January, the National Academy of Sciences, Engineering, and Medicine released a comprehensive review acknowledging that “conclusive or substantial evidence” exists for cannabis’ efficacy in patients suffering from chronic pain.

Cannabinoids have also been well studied as anti-emetic agents and as appetite stimulants. Researchers identified 43 trials evaluating marijuana or its components for these purposes, involving total 2,498 patients. They also identified an additional 14 trials examining the role of cannabis or cannabis-derived extracts in the treatment of multiple sclerosis.

Researchers also identified several additional trials evaluating the use of cannabis for Crohn’s disease, Tourette’s syndrome, Parkinson’s disease, glaucoma, epilepsy, and various other indications.

A 2014 study published in the Journal of the American Medical Association reported that new drugs typically gain FDA approval on the basis of one or two pivotal clinical trials.

Full text of the study, “Medicinal uses of marijuana and cannabinoids,” appears online here.

NORML Blog, Marijuana Law Reform

Categories: Hemp History | Tags: , , , , , , | Leave a comment

Nevada: Oppose The Proposed Tax on Medical Marijuana

Senate Bill 487 would increase the current excise tax on marijuana from two to ten percent of the sales price of the marijuana or product.

While NORML generally does not oppose the imposition of fair and reasonable sales taxes on the commercial sales of cannabis for recreational purposes, we do not support such excessive taxation on medical sales. Most other states that regulate medical cannabis sales do not impose such taxes and Nevada patients should not be forced to pay these excessive costs.

Enter your information below to contact your elected officials and urge them to oppose this measure.

National Organization for the Reform of Marijuana Laws – Advocacy Campaigns

Categories: Industrial Hemp Legislation | Tags: , , , , | Leave a comment

Illinois: Legislation Pending To Expand Industrial Hemp Cultivation

Update: SB 1294 passed the Illinois Senate on May 4 and is now pending in the House

Legislation is pending to regulate the commercial cultivation of industrial hemp.

The Industrial Hemp Act, SB 1294 seeks to license farmers to “grow, process, cultivate, harvest, process, possess, sell, or purchase industrial hemp or industrial hemp related products” for commercial purposes. It expands upon a 2014 law permitting hemp cultivation for agricultural and academic research.

Please use the prewritten letter below to urge lawmakers to support this legislation.

National Organization for the Reform of Marijuana Laws – Advocacy Campaigns

Categories: Industrial Hemp Legislation | Tags: , , , , , , | Leave a comment

California: Legislation To Bring Clarity And Protections For Marijuana Industry

Update: AB 1159 passed the Assembly on 5/15

AB 1159, would bring much-needed clarity to the medical and recreational cannabis industry and extend protections for individuals and businesses in their dealings with their legal advisors 

The current conflict between federal and California law regarding the legality of cannabis creates problems for businesses that are unlike any other industry. 

The fact that cannabis is illegal under federal law – combined with the failure of the current California law to distinguish between what is illegal under federal law in its statutory definition of an illegal contract – discourages clients from pursuing legitimate claims in court. 

Furthermore, the status quo does not provide appropriate protection for attorney-client privilege. 

Enter your information below to send a message to your elected officials in support of this effort. 

Be sure to visit http://www.canorml.org/ and follow California NORML on Facebook and Twitter

National Organization for the Reform of Marijuana Laws – Advocacy Campaigns

Categories: Industrial Hemp Legislation | Tags: , , , , , , | Leave a comment